ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,165.15
5.14%
S&P 500
5,127.57
1.25%
Dow Jones
38,680.19
1.19%
US Dollar vs Yen
152.8095
-0.16%
Brent Oil
83.145
-0.58%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) ニュース

HRTX Heron Therapeautics Inc

2.5886
0.0386 (1.51%)
最終更新日： 01:24:31
15分遅延
名称 銘柄コード 市場 種別
Heron Therapeautics Inc HRTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.0386 1.51% 2.5886 01:24:31
始値 安値 高値 終値 前日終値
2.67 2.575 2.74 2.55
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2421:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
2024/4/1205:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
2024/3/2905:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
2024/3/1405:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
2024/3/1305:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
2024/3/1220:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
2024/2/2822:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
2024/2/1506:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2423:25APSPremarket Heats Up For Biotech Before Opening Bell
2024/1/2422:01EDGAR2Form 8-K - Current report
2024/1/2410:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
2024/1/2011:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2010:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1707:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1206:07EDGAR2Form 8-K - Current report
2024/1/0807:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
2023/12/2306:30EDGAR2Form 8-K - Current report
2023/12/2207:25EDGAR2Form 8-K - Current report
2023/12/0706:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/11/2202:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2100:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1802:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1802:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1602:25APSBiotech Shares Up Sharply Following Quarterly Results
2023/11/1506:10EDGAR2Form 8-K - Current report
2023/11/1506:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
2023/11/0806:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
2023/10/1808:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2505:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2405:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1505:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1505:11EDGAR2Form 8-K - Current report
2023/8/1505:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
2023/8/0805:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
2023/8/0202:56EDGAR2Form D - Notice of Exempt Offering of Securities
2023/7/2605:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2605:13EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/7/2422:12EDGAR2Form 8-K - Current report
2023/7/2422:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
2023/7/2422:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
2023/7/2007:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1806:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有